GGrantIndex
← Search

ORAL YM087 (CI-1025) IN CLASS III CHRONIC HEART FAILURE PTS

$0M01FY2000RRNIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Abstract

The purpose of this study is to test the safety of 3 different doses of a new experimental drug, YM087 in patients with moderately sever Chronic Heart Failure (CHF). Another important reason for this study is to see if taking the oral medicine YM087 for 12 weeks, along with taking your usual medicines for your heart failure, will make you more able to exercise and to do your normal activities.

View original record on NIH RePORTER →